×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INO – inovio pharmaceuticals, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/6
03:46 am
ino
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO
Low
Report
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO
4/6
02:44 am
ino
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
4/5
09:27 pm
ino
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
Low
Report
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
4/4
07:19 am
ino
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
Low
Report
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
4/3
12:44 pm
ino
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Low
Report
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
4/2
06:19 pm
ino
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
Neutral
Report
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
4/2
04:46 pm
ino
INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
Neutral
Report
INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
4/2
12:00 pm
ino
Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Date
Time
Symbol
Company Name
Action
%Chg
3/12/2026
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-2.4%
inovio pharmaceuticals, inc.
11/10/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
MISS
Report
-7.0%
inovio pharmaceuticals, inc.
8/12/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
14.1%
inovio pharmaceuticals, inc.
5/13/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-2.1%
inovio pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
04:57 pm
ino
Form 424B5 INOVIO PHARMACEUTICALS,
Low
Report
Form 424B5 INOVIO PHARMACEUTICALS,
4/2
06:15 am
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Apr 01
High
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Apr 01
4/2
06:06 am
ino
Form 424B5 INOVIO PHARMACEUTICALS,
High
Report
Form 424B5 INOVIO PHARMACEUTICALS,
4/1
05:05 pm
ino
Form 4 INOVIO PHARMACEUTICALS, For: Mar 31 Filed by: Sumner Michael John
High
Report
Form 4 INOVIO PHARMACEUTICALS, For: Mar 31 Filed by: Sumner Michael John
3/12
04:07 pm
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 12
Low
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 12
3/12
04:02 pm
ino
Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31
Low
Report
Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31
3/5
04:55 pm
ino
Form 4 INOVIO PHARMACEUTICALS, For: Mar 04 Filed by: Sumner Michael John
Low
Report
Form 4 INOVIO PHARMACEUTICALS, For: Mar 04 Filed by: Sumner Michael John
3/5
04:55 pm
ino
Form 4 INOVIO PHARMACEUTICALS, For: Mar 04 Filed by: Shea Jacqueline Elizabeth
Low
Report
Form 4 INOVIO PHARMACEUTICALS, For: Mar 04 Filed by: Shea Jacqueline Elizabeth
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/3
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
66.7%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
TOP News Decliners
3/9
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 03
-47.6%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: